P. Schwarzenberger

发表

J. Kolls, Q. Zhong, P. Schwarzenberger, 2002, Cellular and Molecular Life Sciences CMLS.

Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense

J. Shellito, J. Kolls, J. Peschon, 2001, The Journal of experimental medicine.

Hematopoietic Stem Cells

J. Kolls, P. Schwarzenberger, V. Russa, 2002, Cancer investigation.

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.

J. Shellito, J. Kolls, G. Bagby, 2001, American journal of respiratory cell and molecular biology.

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.

P. Schwarzenberger, Weitao Huang, P. Fidel, 2004, The Journal of infectious diseases.

Propylthiouracil reduces xenograft tumor growth in an athymic nude mouse prostate cancer model.

P. Schwarzenberger, C. Theodossiou, 2000, The American journal of the medical sciences.

Marrow Stem Cells, Mesenchymal Progenitor Cells, and Stromal Progeny

J. Kolls, P. Schwarzenberger, V. L. La Russa, 2002, Cancer investigation.

IL-1-Independent Role of IL-17 in Synovial Inflammation and Joint Destruction During Collagen-Induced Arthritis1

L. Joosten, J. Kolls, W. B. van den Berg, 2001, The Journal of Immunology.

Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407

Ying Cheng, L. Paz-Ares, He-long Zhang, 2021, JTO clinical and research reports.

Dose Escalation of Once Weekly Oral Vinorelbine Concurrent With Weekly Split Dose Hypofractionated Chest Radiation for Palliation of Advanced Non–Small Cell Lung Cancer: A Phase I/II Study

L. Nedzi, P. Schwarzenberger, O. Salazar, 2011, The American journal of the medical sciences.

Dose Escalation of Docetaxel Concomitant With Hypofractionated, Once Weekly Chest Radiotherapy for Non-Small-Cell Lung Cancer: A Phase I Study

P. Schwarzenberger, R. Wynn, C. Theodossiou, 2004, American journal of clinical oncology.

Critical role of IL‐17 receptor signaling in acute TNBS‐induced colitis

J. Kolls, P. Schwarzenberger, J. Bindas, 2006, Inflammatory bowel diseases.

Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection.

D. Longo, J. Keller, P. Schwarzenberger, 1996, Blood.

Phase 2 trial of Allovectin-7 in advanced metastatic melanoma

M. Atkins, J. Nemunaitis, R. Gonzalez, 2006, Melanoma research.

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.

P. Schwarzenberger, R. Lilenbaum, S. Lane, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Chimerism analysis in sex-mismatched murine transplantation using quantitative real-time PCR.

J. Kolls, Q. Zhong, P. Schwarzenberger, 2002, BioTechniques.

Activation of Tumor Necrosis Factor-α-converting Enzyme-mediated Ectodomain Shedding by Nitric Oxide*

J. Lancaster, J. Kolls, P. Schwarzenberger, 2000, The Journal of Biological Chemistry.

Targeted agents for chronic myelogenous leukemia: will that be the end of allogeneic bone marrow transplantation for that disease?

P. Schwarzenberger, Rongrong Liu, Jie Yang, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma.

A. Marrogi, J. Kolls, P. Schwarzenberger, 2000, The Annals of thoracic surgery.

Plasmacytoma in HIV disease: two case reports and review of the literature.

P. Schwarzenberger, C. Theodossiou, R. Burroughs, 1998, The American journal of the medical sciences.

Oncofetal antigen/immature laminin receptor protein in pregnancy and cancer

P. Schwarzenberger, A. Barsoum, 2014, Cellular & Molecular Biology Letters.

Non-Hodgkin's lymphomas.

P. Schwarzenberger, C. Theodossiou, 2002, Clinical obstetrics and gynecology.

IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines.

A. Miller, J. Kolls, G. Bagby, 1998, Journal of immunology.

Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells.

J. Kolls, G. Bagby, D. Stoltz, 2001, Alcoholism, clinical and experimental research.

Inhibition of TNF‐α processing and TACE‐mediated ectodomain shedding by ethanol

J. Shellito, J. Kolls, W. Summer, 2000, Journal of leukocyte biology.

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

L. Joosten, J. Kolls, W. B. van den Berg, 2005, Arthritis and rheumatism.

The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study.

R. Ramesh, A. Marrogi, S. Freeman, 1998, Human gene therapy.

Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study

A. Marrogi, J. Kolls, P. Schwarzenberger, 2011, Cancer Gene Therapy.

Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.

P. Friedlander, J. Kolls, P. Schwarzenberger, 2003, Cancer research.

Phase I trial of IL-2 plasmid DNA with electroporation in metastatic melanoma

R. Gonzalez, L. Selk, P. Schwarzenberger, 2007 .

CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route

P. Schwarzenberger, K. Eberle, M. Freistadt, 2013, Cancer Gene Therapy.

Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis1

J. Kolls, G. Bagby, P. Schwarzenberger, 2000, The Journal of Immunology.

Acute alcohol intoxication suppresses the CXC chemokine response during endotoxemia.

J. Kolls, G. Bagby, Ping Zhang, 2002, Alcoholism, clinical and experimental research.

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

J. Wolchok, H. Maecker, A. Shoushtari, 2020, Clinical Cancer Research.

IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells.

J. Shellito, J. Kolls, W. Summer, 1999, Journal of immunology.

IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1

L. Joosten, J. Kolls, W. B. van den Berg, 2003, The Journal of Immunology.

Ligand / Osteoprotegerin Balance B κ the Receptor Activator of NF-Collagen-Induced Arthritis Through Loss of IL-17 Promotes Bone Erosion in Murine

J. H. van den Berg, L. Joosten, J. Kolls, 2003 .

Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction

P. Schwarzenberger, E. Lubberts, W. B. Berg, 2002, Inflammation Research.

Collagen-Induced Arthritis Inflammation and Joint Destruction During IL-1-Independent Role of IL-17 in Synovial

L. Joosten, P. Schwarzenberger, E. Lubberts, 2001 .

Adenoviral-mediated interferon-gamma gene therapy augments pulmonary host defense of ethanol-treated rats.

J. Shellito, J. Kolls, G. Bagby, 1998, Alcoholism, clinical and experimental research.

CD4+ T cell-independent DNA vaccination against opportunistic infections.

J. Shellito, J. Kolls, A. Ramsay, 2005, The Journal of clinical investigation.

Retrovirus molecular conjugates: a versatile and efficient gene transfer vector system for primitive human hematopoietic progenitor cells

G. Yang, P. Schwarzenberger, W. Huang, 2006, Cancer Gene Therapy.

Immunomodulation and adenoviral gene transfer to the lungs of nonhuman primates.

D. Sullivan, J. Shellito, J. Kolls, 2000, Human gene therapy.

IFN-g and CD8 T Cells Restore Host Defenses Against Pneumocystis cariniiin Mice Depleted of CD4 T Cells

J. Shellito, J. Kolls, W. Summer, 1999 .

IFN-g and CD 8 1 T Cells Restore Host Defenses Against Pneumocystis carinii in Mice Depleted of CD 4 1 T Cells 1

J. Shellito, J. Kolls, W. Summer, 1999 .

ATIM-12. PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB [DUR]) IN PATIENTS WITH BEVACIZUMAB (BEV)-REFRACTORY RECURRENT GLIOBLASTOMA (GBM).

Andrew J. Park, T. Cloughesy, T. Kaley, 2017 .

Phase 2 study to evaluate safety and efficacy of MEDI4736 (durvalumab [DUR]) in glioblastoma (GBM) patients: An update.

Andrew J. Park, T. Cloughesy, T. Kaley, 2017 .

A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC).

G. Coukos, P. Sabbatini, P. Schwarzenberger, 2018, Annals of Oncology.

Requirement of TPO/c‐mpl for IL‐17A‐induced granulopoiesis and megakaryopoiesis

J. Kolls, P. Schwarzenberger, Weitao Huang, 2013, Journal of leukocyte biology.

IL-17 Receptor Knockout Mice Have Enhanced Myelotoxicity and Impaired Hemopoietic Recovery Following Gamma Irradiation

Q. Zhong, P. Schwarzenberger, Weitao Huang, 2006, The Journal of Immunology.

IrradiationHemopoietic Recovery Following Gamma Enhanced Myelotoxicity and Impaired IL-17 Receptor Knockout Mice Have

Q. Zhong, P. Schwarzenberger, Weitao Huang, 2006 .

Poly-l-lysine-Based Molecular Conjugate Vectors:: A High Efficiency Gene Transfer System for Human Progenitor and Leukemia Cells

J. Kolls, P. Schwarzenberger, P. Oliver, 2001, The American journal of the medical sciences.

Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics

J. Kolls, P. Schwarzenberger, C. Theodossiou, 1997, Journal of virology.

Early stage breast cancer.

P. Schwarzenberger, D. Schapira, C. Theodossiou, 1997, Oncology reports.

Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature.

P. Schwarzenberger, C. Theodossiou, J. Ellis, 1999, The American journal of the medical sciences.

Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)

Yu-Hong Chen, Xiao-jun Huang, P. Schwarzenberger, 2014, Journal of Hematology & Oncology.

Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis

P. Schwarzenberger, J. Yang, W. Li, 2009, Bone Marrow Transplantation.

Interleukin‐17A: A T‐Cell‐Derived Growth Factor for Murine and Human Mesenchymal Stem Cells

P. Schwarzenberger, Weitao Huang, V. L. La Russa, 2006, Stem cells.

Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, DUR) + tremelimumab (TRE) in patients with advanced solid tumors.

Andrew J. Park, J. Wolchok, J. Nemunaitis, 2017 .

IL-17-Mediated Granulopoiesis and Granulocyte-Colony-Stimulating Factor Requirement of Endogenous Stem Cell Factor

J. Kolls, G. Bagby, P. Schwarzenberger, 2000 .

Clinical Protocol The Treatment of Malignant Mesothelioma with a Gene Modified Cancer Cell Line: A Phase I Study

R. Ramesh, A. Marrogi, S. Freeman, 1998 .

CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

J. Shellito, J. Kolls, Q. Zhong, 2001, The Journal of clinical investigation.

Interleukin-17/Interleukin-17 Receptor-Mediated Signaling Is Important for Generation of an Optimal Polymorphonuclear Response against Toxoplasma gondii Infection

J. Schwartzman, I. Khan, M. Kelly, 2005, Infection and Immunity.

Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): A model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans

P. Schwarzenberger, Ping K. Ruan, Chun Yang, 2012, Virology Journal.

973MO KEYNOTE-189 5-year update: First-line pembrolizumab (pembro) + pemetrexed (pem) and platinum vs placebo (pbo) + pem and platinum for metastatic nonsquamous NSCLC

P. Schwarzenberger, J. Gray, M. Reck, 2022, Annals of Oncology.

Efficient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem Cells

J. Kolls, Q. Zhong, P. Schwarzenberger, 2001, Journal of Virology.

Retrovirus Molecular Conjugates

J. Kolls, Q. Zhong, P. Schwarzenberger, 2001, The Journal of Biological Chemistry.

Efﬁcient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem Cells

J. Kolls, Q. Zhong, P. Schwarzenberger, 2001 .

Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.

L. Pannell, P. Schwarzenberger, A. Barsoum, 2009, Biomaterials.

IFN-γ and CD8+ T Cells Restore Host Defenses Against Pneumocystis carinii in Mice Depleted of CD4+ T Cells

J. Shellito, J. Kolls, W. Summer, 1999, The Journal of Immunology.

Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor.

D. Curiel, J. Keller, P. Schwarzenberger, 1996, Blood.

Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells.

Xian-Yang Zhang, J. Reiser, J. Kolls, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Cloning and characterization of the prostate‐specific membrane antigen promoter

M. Batzer, J. Eastham, R. Rhoads, 1999, Journal of cellular biochemistry.

Reactive oxygen species mediate tumor necrosis factor alpha‐converting, enzyme‐dependent ectodomain shedding induced by phorbol myristate acetate

J. Lancaster, J. Kolls, P. Schwarzenberger, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Phase II Study of LucanixTM (Belagenpumatucel) a Transforming Growth Factor β2 (TGF-β2) Antisense Gene Modified Allogeneic Tumor Cell Vaccine in Non Small Cell Lung Cancer (NSCLC)

J. Nemunaitis, P. Schwarzenberger, R. Dillman, 2016 .

Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.

N. Senzer, J. Nemunaitis, P. Schwarzenberger, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancer.

G. Shapiro, R. Bukowski, P. Schwarzenberger, 2008, Clinical lung cancer.

IL-17 Mobilizes Peripheral Blood Stem Cells with Short- and Long-Term Repopulating Ability in Mice1

J. Kolls, P. Schwarzenberger, P. Oliver, 2001, The Journal of Immunology.

Ability in Mice with Short- and Long-Term Repopulating IL-17 Mobilizes Peripheral Blood Stem Cells

J. Kolls, P. Schwarzenberger, P. Oliver, 2001 .

Development of a gene therapy based bone marrow purging system for leukemias

Q. Zhong, P. Schwarzenberger, Weitao Huang, 2005, Cancer Gene Therapy.

Interleukin 17: An example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis

J. Kolls, P. Schwarzenberger, 2002, Journal of cellular biochemistry. Supplement.

Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice.

K. Ley, J. Kolls, P. Schwarzenberger, 2001, Blood.

Requirement of IL-17 Receptor Signaling in Radiation-Resistant Cells in the Joint for Full Progression of Destructive Synovitis1

J. Kolls, W. B. van den Berg, J. Peschon, 2005, The Journal of Immunology.

Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.

P. Ye, R. Ramesh, A. Marrogi, 1998, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma.

P. Ye, S. Freeman, J. Kolls, 1998, American journal of respiratory cell and molecular biology.

IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.

J. Kolls, A. Ramsay, Kong Chen, 2010, Experimental hematology.

A Phase 2 Randomized Trial of Paclitaxel and Carboplatin with or without Panitumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Daniel J. Freeman, J. Crawford, D. Prager, 2013, Journal of Thoracic Oncology.

Method for In Vivo Evaluation of Cytokines of an Alternate, Novel Gene Therapy-Derived IL-17 Stimulates Granulopoiesis in Mice: Use

J. Kolls, G. Bagby, D. Stoltz, 1998 .

Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC).

S. Severi, O. Sartor, P. Schwarzenberger, 2016, Clinical advances in hematology & oncology : H&O.

Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.

R. Ramlau, J. Jassem, J. R. Pereira, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IL-17F/IL-17R interaction stimulates granulopoiesis in mice.

Q. Zhong, P. Schwarzenberger, Weitao Huang, 2008, Experimental hematology.

ATIM-38. PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) + BEVACIZUMAB (BEV) IN BEV-NAÏVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

Andrew J. Park, T. Cloughesy, T. Kaley, 2018, Neuro-Oncology.

97O First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407

A. Tafreshi, Ying Cheng, B. Halmos, 2021 .

269 CRITICAL ROLE OF INTERLEUKIN-17 AND INTERLEUKIN-17 RECEPTOR SIGNALING IN TNBS-INDUCED COLITIS.

J. Kolls, P. Schwarzenberger, J. Bindas, 2006, Journal of Investigative Medicine.

Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer.

M. Ismail, A. Fernando, R. Gaur, 2009, Frontiers in bioscience.

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407

Y. Hosomi, M. Okada, H. Saka, 2023, Cancer science.

Circulating Immune Cell and Outcome Analysis from the Phase 2 Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.

Raymond Y Huang, Andrew J. Park, T. Creasy, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

R. Ramlau, J. Jassem, P. Zatloukal, 2005 .

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

E. Felip, E. Esteban, M. Pietanza, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

A. Tafreshi, Ying Cheng, B. Halmos, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of HLA-b7 plasmid dna/lipid (allovectin-7®) immunotherapy in patients with metastatic melanoma

M. Atkins, R. Gonzalez, L. Hutchins, 2001 .

Requirement of IL-17 Receptor Signaling in Radiation-Resistant Cells in the Joint for Full Progression of Destructive Synovitis1

J. Kolls, W. B. van den Berg, J. Peschon, 2005, The Journal of Immunology.

Progression of Destructive Synovitis FullRadiation-Resistant Cells in the Joint for Requirement of IL-17 Receptor Signaling in

J. Peschon, P. Schwarzenberger, Weitao Huang, 2005 .

337 Intratumoral immune therapy for recurrent breast cancer with polyICLC, and tremelimumab combined with systemic durvalumab

I. Puzanov, C. Slingluff, P. Friedlander, 2021, Journal for ImmunoTherapy of Cancer.

Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) + radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).

Andrew J. Park, T. Cloughesy, T. Kaley, 2019, Journal of Clinical Oncology.

First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices

Xiaohan Hu, P. Schwarzenberger, Stephen V. Liu, 2022, JTO clinical and research reports.

Phase 1 study to evaluate the safety and efficacy of immunotherapy with tremelimumab and durvalumab in multiple myeloma patients receiving high dose chemotherapy and autologous stem cell transplant (HDT/ASCT) + peripheral blood lymphocyte (PBL) reinfusion.

A. Lesokhin, P. Schwarzenberger, R. Venhaus, 2017 .

Requirement of local synovial IL-17 receptor signaling in the progression of chronic synovitis and bone erosion in arthritis

J. Peschon, P. Schwarzenberger, E. Lubberts, 2004 .

Corrigendum. CD4+ T cell-independent DNA vaccination against opportunistic infections.

J. Shellito, J. Kolls, A. Ramsay, 2015, Journal of Clinical Investigation.